BridgeBio Pharma Reports Topline Results from Phase 1/2 Trial of Investigational Gene Therapy for Congenital Adrenal Hyperplasia (CAH)
- Increase in endogenous cortisol production achieved in all patients in higher dose cohorts of BBP-631, a result seen for the first time ever in CAH patients
Cardinal Health, Inc. (CAH) Baird's 2024 Global Healthcare Conference (Transcript)
Cardinal Health, Inc. (NYSE:CAH ) Baird's 2024 Global Healthcare Conference September 10, 2024 9:05 AM ET Company Participants Matt Sims - VP, IR Jason Hollar - CEO Aaron Alt - CFO Conference Call ...
Cardinal Health (CAH) Advances But Underperforms Market: Key Facts
The latest trading day saw Cardinal Health (CAH) settling at $112.80, representing a +0.92% change from its previous close.
Reasons to Retain Cardinal Health Stock in Your Portfolio Now
CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.
Greenville Center to Boost CAH Stock's at-Home Solution Business
Cardinal Health announces the opening of its new distribution center in Greenville to support its at-Home Solutions business.
Cardinal Health Board of Directors Approves Quarterly Dividend
DUBLIN, Ohio , Aug. 15, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5056 per share out of the Company's capital ...
Cardinal Health Beats Estimates, Boosts Guidance on Strong Drug Sales
Shares of Cardinal Health (CAH) gained in intraday trading Wednesday as the provider of healthcare services and products posted better-than-anticipated results and raised its outlook on strong drug...
Cardinal Health (CAH) Q4 Earnings and Revenues Top Estimates
Cardinal Health (CAH) came out with quarterly earnings of $1.84 per share, beating the Zacks Consensus Estimate of $1.72 per share. This compares to earnings of $1.55 per share a year ago.
Cardinal Health Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Cardinal Health, Inc. CAH is set to release earnings results for its fourth quarter, before the opening bell on Aug. 14, 2024.
Seeking Clues to Cardinal (CAH) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
Beyond analysts' top -and-bottom-line estimates for Cardinal (CAH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quar...
Cardinal Health (CAH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Cardinal (CAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cardinal Health: Growth Headwinds Ahead
Cardinal Health's recent dividend raise (about 1%) reflects growth pressure ahead. With a ~13x P/E, valuation seems reasonable on the surface. However, when adjusted for growth, the current valuati...
Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2024 on August 14
DUBLIN, Ohio , July 23, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2024 on August 14, prior to the opening o...
Why the Market Dipped But Cardinal Health (CAH) Gained Today
Cardinal Health (CAH) closed at $95.97 in the latest trading session, marking a +0.59% move from the prior day.
Cardinal Health (CAH) Stock Sinks As Market Gains: Here's Why
Cardinal Health (CAH) concluded the recent trading session at $93.74, signifying a -0.38% move from its prior day's close.
Related Companies